Tokyo, Japan

Takatsugu Murata

This inventor holds 1 USPTO granted patent. Top assignees: National Cancer Center, Tokyo University of Science Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takatsugu Murata. Retrieved from https://idiyas.com/inventor/takatsugu-murata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takatsugu Murata: Innovator in Cancer Treatment

Introduction

Takatsugu Murata is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His innovative work has led to the creation of a unique compound that holds promise for improving cancer therapies.

Latest Patents

Murata holds a patent for a compound, production method therefor, and pharmaceutical composition. This compound is represented by a specific formula and is useful for treating cancer. The patent details a production method that enables the compound to be produced with high efficiency. Additionally, the pharmaceutical composition contains the compound as an active ingredient, showcasing its potential in medical applications.

Career Highlights

Throughout his career, Takatsugu Murata has worked with esteemed institutions such as the Tokyo University of Science Foundation and the National Cancer Center. His work in these organizations has allowed him to focus on research that directly impacts cancer treatment and patient care.

Collaborations

Murata has collaborated with notable colleagues, including Isamu Shiina and Motoyuki Shimonaka. These partnerships have contributed to the advancement of his research and the successful development of his patented compound.

Conclusion

Takatsugu Murata's innovative work in the field of cancer treatment exemplifies the impact of dedicated research and collaboration. His contributions continue to pave the way for advancements in pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…